Fonseca F - Search Results

1

Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy.

Vallecillo G, Mojal S, Roquer A, Martinez D, Rossi P, Fonseca F, Muga R, Torrens M. Vallecillo G, et al. Among authors: fonseca f. Clin Infect Dis. 2013 Oct;57(8):1189-94. doi: 10.1093/cid/cit467. Epub 2013 Jul 29. Clin Infect Dis. 2013. PMID: 23899678

2

Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.

Torrens M, Fonseca F, Mateu G, Farré M. Torrens M, et al. Among authors: fonseca f. Drug Alcohol Depend. 2005 Apr 4;78(1):1-22. doi: 10.1016/j.drugalcdep.2004.09.004. Epub 2004 Nov 11. Drug Alcohol Depend. 2005. PMID: 15769553 Review.

3

BDNF variability in opioid addicts and response to methadone treatment: preliminary findings.

de Cid R, Fonseca F, Gratacòs M, Gutierrez F, Martín-Santos R, Estivill X, Torrens M. de Cid R, et al. Among authors: fonseca f. Genes Brain Behav. 2008 Jul;7(5):515-22. doi: 10.1111/j.1601-183X.2007.00386.x. Genes Brain Behav. 2008. PMID: 18182069 Free article.

4

Prevalence of long QTc interval in methadone maintenance patients.

Fonseca F, Marti-Almor J, Pastor A, Cladellas M, Farré M, de la Torre R, Torrens M. Fonseca F, et al. Drug Alcohol Depend. 2009 Jan 1;99(1-3):327-32. doi: 10.1016/j.drugalcdep.2008.06.018. Epub 2008 Sep 5. Drug Alcohol Depend. 2009. PMID: 18774239

5

Anticonvulsant drugs in cocaine dependence: a systematic review and meta-analysis.

Alvarez Y, Farré M, Fonseca F, Torrens M. Alvarez Y, et al. Among authors: fonseca f. J Subst Abuse Treat. 2010 Jan;38(1):66-73. doi: 10.1016/j.jsat.2009.07.001. Epub 2009 Aug 29. J Subst Abuse Treat. 2010. PMID: 19717271 Review.

6

Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.

Fonseca F, Gratacòs M, Escaramís G, De Cid R, Martín-Santos R, Fernández-Espejo E, Estivill X, Torrens M. Fonseca F, et al. Mol Diagn Ther. 2010 Jun 1;14(3):171-8. doi: 10.1007/BF03256370. Mol Diagn Ther. 2010. PMID: 20560679

7

Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response.

Fonseca F, de la Torre R, Díaz L, Pastor A, Cuyàs E, Pizarro N, Khymenets O, Farré M, Torrens M. Fonseca F, et al. PLoS One. 2011 May 12;6(5):e19527. doi: 10.1371/journal.pone.0019527. PLoS One. 2011. PMID: 21589866 Free PMC article.

8

[Access to treatment for people with alcohol and other substance abuse problems].

Gilchrist G, Fonseca F, Torrens M. Gilchrist G, et al. Among authors: fonseca f. Adicciones. 2011;23(4):343-8. Adicciones. 2011. PMID: 22249899 Free article. Spanish.

9

Methadone maintenance treatment in Spain: the success of a harm reduction approach.

Torrens M, Fonseca F, Castillo C, Domingo-Salvany A. Torrens M, et al. Among authors: fonseca f. Bull World Health Organ. 2013 Feb 1;91(2):136-41. doi: 10.2471/BLT.12.111054. Bull World Health Organ. 2013. PMID: 23554526 Free PMC article.

10

ALDH5A1 variability in opioid dependent patients could influence response to methadone treatment.

Fonseca F, Gratacòs M, Escaramís G, De Cid R, Martín-Santos R, Farré M, Estivill X, Torrens M. Fonseca F, et al. Eur Neuropsychopharmacol. 2014 Mar;24(3):420-4. doi: 10.1016/j.euroneuro.2013.10.003. Epub 2013 Oct 18. Eur Neuropsychopharmacol. 2014. PMID: 24230997

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,632 results

Search Page

Filters